Analysts Predict 12% Rally for UNH Amid Improving Medical Cost Trends

Analysts at BofA and Morgan Stanley have raised their price targets for UnitedHealth Group Inc. (UNH) after noting improving medical cost trends and a favorable second-quarter earnings setup.

Morgan Stanley analyst Erin Wright upgraded the stock to 'Overweight' with a price target of $453, implying over 12% upside potential from current levels. Wright attributed this optimism to emerging signs of softer utilization trends in managed care stocks.

Wright also highlighted AI tailwinds for managed care organizations across revenue and cost levers, estimating that AI-driven efficiencies could deliver roughly 45% average earnings-per-share upside as efficiency scales.

BofA analyst Kevin Fischbeck upgraded UNH to 'Buy' from 'Neutral', with a price target of $450. Fischbeck noted that incoming data points made it difficult to believe the strong first quarter was solely due to weak flu and storms, citing improving medical cost trends and supportive near-term data points.

Truist also raised its price target on UNH to $440 from $395, maintaining a 'Buy' rating. The firm expects meaningful embedded earnings potential tied to ongoing margin recovery across government businesses and continued solid trends in the Commercial business.